Piers DA - Search Results

1

Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.

de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, Boonstra H, van der Zee AG. de Hullu JA, et al. Among authors: piers da. J Nucl Med. 1998 Aug;39(8):1381-5. J Nucl Med. 1998. PMID: 9708512 Free article.

2

Sentinel node biopsy as a surgical staging method for solid cancers.

Koops HS, Doting MH, de Vries J, Tiebosch AT, Plukker JT, Hoekstra HJ, Piers DA. Koops HS, et al. Among authors: piers da. Radiother Oncol. 1999 Apr;51(1):1-7. doi: 10.1016/s0167-8140(99)00024-9. Radiother Oncol. 1999. PMID: 10386710

3

Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva.

de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, Aalders JG, van Der Zee AG. de Hullu JA, et al. Among authors: piers da. J Clin Oncol. 2000 Aug;18(15):2811-6. doi: 10.1200/JCO.2000.18.15.2811. J Clin Oncol. 2000. PMID: 10920128 Clinical Trial.

4

Sentinel lymph node detection in locally recurrent carcinoma of the vulva.

de Hullu JA, Piers DA, Hollema H, Aalders JG, van der Zee AG. de Hullu JA, et al. Among authors: piers da. BJOG. 2001 Jul;108(7):766-8. doi: 10.1111/j.1471-0528.2001.00172.x. BJOG. 2001. PMID: 11467708 No abstract available.

5

Sentinel node biopsy for melanoma in the head and neck region.

Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, Vermey A, Plukker JT, Hoefnagel CA, Piers DA, Kroon BB. Jansen L, et al. Among authors: piers da. Head Neck. 2000 Jan;22(1):27-33. doi: 10.1002/(sici)1097-0347(200001)22:1<27::aid-hed5>3.0.co;2-z. Head Neck. 2000. PMID: 10585602 Clinical Trial.

6

Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.

Doting MH, Jansen L, Nieweg OE, Piers DA, Tiebosch AT, Koops HS, Rutgers EJ, Kroon BB, Peterse JL, Olmos RA, de Vries J. Doting MH, et al. Among authors: piers da. Cancer. 2000 Jun 1;88(11):2546-52. Cancer. 2000. PMID: 10861432 Clinical Trial.

7

99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.

Bakker M, van der Graaf WT, Piers DA, Franssen EJ, Groen HJ, Smit EF, Kool W, Hollema H, Müller EA, De Vries EG. Bakker M, et al. Among authors: piers da. Anticancer Res. 1999 May-Jun;19(3B):2349-53. Anticancer Res. 1999. PMID: 10472354

8

Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.

Kengen RA, Meijer S, Beekhuis H, Piers DA. Kengen RA, et al. Among authors: piers da. J Nucl Med. 1991 Sep;32(9):1709-12. J Nucl Med. 1991. PMID: 1831839 Free article.

9

L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.

Jager PL, Groen HJ, van der Leest A, van Putten JW, Pieterman RM, de Vries EG, Piers DA. Jager PL, et al. Among authors: piers da. J Nucl Med. 2001 Apr;42(4):579-85. J Nucl Med. 2001. PMID: 11337545 Free article.

10

Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma.

Smit AJ, van Essen LH, Hollema H, Muskiet FA, Piers DA. Smit AJ, et al. Among authors: piers da. J Nucl Med. 1984 Sep;25(9):984-6. J Nucl Med. 1984. PMID: 6470814 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters